Burning Rock Biotech (BNR) Shares Outstanding (2019 - 2026)

Burning Rock Biotech's Shares Outstanding (Entity) history runs 7 years deep, the most recent figure standing at $5.4 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Entity) rose 3.94% year-over-year to $5.4 million; the TTM figure through Dec 2025 stood at $5.4 million (up 3.94% YoY), while the FY2025 annual figure was $5.4 million, up 3.94% from the prior year.
• Shares Outstanding (Entity) for Q4 2025 stood at $5.4 million, down from $5.5 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $63.7 million in Q4 2021, with the low at $5.2 million in Q1 2024.
• The 5-year median for Shares Outstanding (Entity) is $51.6 million (2023), against an average of $34.1 million.
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) tumbled 89.98% in 2024, then gained 5.96% in 2025.
• Burning Rock Biotech's Shares Outstanding (Entity) stood at $63.7 million in 2021, then fell by 17.62% to $52.5 million in 2022, then retreated by 1.75% to $51.6 million in 2023, then plunged by 89.94% to $5.2 million in 2024, then rose by 3.94% to $5.4 million in 2025.
• Business Quant data shows BNR's Shares Outstanding (Entity) at $5.4 million in Q4 2025, $5.5 million in Q3 2025, and $5.5 million in Q2 2025.